KOVALTRY®

KOVALTRY, Antihemophilic Factor (Recombinant), is a recombinant, human DNA sequence derived, full length Factor VIII concentrate indicated for use in adults and children with hemophilia A (congenital Factor VIII deficiency) for:

  • On-demand treatment and control of bleeding episodes
  • Perioperative management of bleeding
  • Routine prophylaxis to reduce the frequency of bleeding episodes

KOVALTRY is not indicated for the treatment of von Willebrand disease

For indications, dosing and other information, please refer to the prescribing information.

KOVALTRY® ‐ Bayer

Size:
250 unit, 2.5 mL vial
NDC #:
00026-3821-25
Download:
PI
Size:
500 unit, 2.5 mL vial
NDC #:
00026-3822-25
Download:
PI
Size:
1000 unit, 2.5 mL vial
NDC #:
00026-3824-25
Download:
PI
Size:
2000 unit, 5 mL vial
NDC #:
00026-3826-50
Download:
PI
Size:
3000 unit, 5 mL vial
NDC #:
00026-3828-50
Download:
PI